OVERLOOK MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $2.8M
- Transactions
- 380
- Companies
- 40
- Average per transaction
- $7,255
Who reported the payments
| Bristol Myers Squibb | $638,207 |
| Regeneron | $256,368 |
| Amgen | $240,051 |
| Merck | $190,334 |
| Novartis | $169,358 |
| Bayer | $152,502 |
| Biosense Webster, Inc. | $148,668 |
| Genentech, Inc. | $143,657 |
| Penumbra, Inc. | $136,520 |
| AstraZeneca | $133,991 |
| Hologic Sales And Service, LLC | $109,091 |
| Sanofi | $94,675 |
| Beigene, Ltd. | $60,134 |
| Janssen Research & Development, LLC | $47,845 |
| Sanofi US Services Inc. | $36,685 |
| Astellas Pharma Global Development | $26,000 |
| Takeda Pharmaceuticals U.S.A., Inc. | $21,516 |
| AbbVie | $20,548 |
| Tesaro, Inc. | $17,920 |
| Premia Spine, Ltd. | $16,761 |
| E.r. Squibb & Sons, L.L.C. | $10,038 |
| Genentech USA, Inc. | $8,750 |
| Boston Scientific | $8,718 |
| Siemens Medical Solutions USA, Inc. | $8,215 |
| Exelixis Inc. | $7,303 |
| Sanofi Pasteur Inc. | $6,900 |
| Eisai Inc. | $6,805 |
| Roche Products Limited | $6,250 |
| Medical Device Business Services, Inc. | $5,450 |
| Astrazeneca UK Limited | $4,250 |
| Acell, Inc. | $4,060 |
| ZOLL Circulation Inc | $4,010 |
| Merit Medical Systems Inc | $3,000 |
| CSL Behring | $2,595 |
| Johnson & Johnson | $2,100 |
| Morphosys AG | $1,600 |
| W. L. Gore & Associates, Inc. | $1,500 |
| MDD US Operations, LLC | $1,000 |
| Emmaus Medical, Inc. | $1,000 |
| Bioventus LLC | $906 |